Safety labeling updates & new warnings.
- Published in:
- Formulary, 2008, v. 43, n. 4, p. 146
- Publication type:
- Article
Works matching DE "UNITED States. Food %26 Drug Administration. Oncologic Drugs Advisory Committee"
Results: 11
1
2
Canadian Consensus Conference: The FDA decision on the use of 5ARIs.
- Published in:
- 2012
- By:
- Publication type:
- Proceeding
3
Accelerated Drug Approval: FDA May Get Tougher; Companies Cite Hurdles.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 6, p. 455, doi. 10.1093/jnci/djr087
- By:
- Publication type:
- Article
4
Regulators, Researchers Seek to Streamline Cancer Trials.
- Published in:
- Applied Clinical Trials, 2013, v. 22, n. 5, p. 8
- By:
- Publication type:
- Article
5
Raloxifene examined for breast cancer prevention.
- Published in:
- American Journal of Health-System Pharmacy, 2007, v. 64, n. 17, p. 1774, doi. 10.2146/news070075
- By:
- Publication type:
- Article
6
Changes for ESAs.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 5, p. 483, doi. 10.1038/nbt0508-483b
- By:
- Publication type:
- Article
7
Pazopanib Receives Unanimous FDA Panel Approval Recommendation.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 11, p. 928
- Publication type:
- Article
8
ODAC Recommends Approval of Pegylated Interferon Alfa-2b for Malignant Melanoma.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 11, p. 928
- Publication type:
- Article
9
FDA Extends Review of Ofatumumab.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 10, p. 810
- Publication type:
- Article
10
Accelerated Approval Recommended for Nelarabine in T-Cell Leukemia/Lymphoma.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 11, p. 1
- Publication type:
- Article
11
ODAC Recommends Lenalidomide for Full Approval in Select MDS Patients.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 11, p. 1
- Publication type:
- Article